AtriCure, Inc.
AtriCure develops and sells devices for surgical ablation, exclusion of the left atrial appendage, and temporary pain relief. Products include Isolator Synergy Clamps, multifunctional pens, linear ablation devices, cryoablation systems, EPi-Sense Systems, cryoSPHERE probe, AtriClip System, LARIAT System, Lumitip dissectors, Glidepath guides, Subtle Cannulas, and reusable cardiac instruments.
Overview
Sector
Medical Instruments & Supplies
Strengths
- Pricing power: gross margin has held between 72% and 75% over the last 7 years (latest 75.0%).
- Consistent growth: revenue has compounded at 15.0% a year over 6 years, rising in 5 of them.
Weaknesses
- Operating profit does not cover interest expense.
- Our discounted cash flow model finds no value to support the current price: operating profit does not cover interest expense.
- Currently loss-making: the latest fiscal year closed with a net loss.
- Unreliable cash generation: free cash flow was negative in 6 of the last 7 years.
- Unstable profitability: operating margin ranged from -22% to -2% over the last 7 years, with operating losses in 7 of them.
- Valued at a premium to its Medical Instruments & Supplies peers: P/FCF 68.9x vs. a median of 23.9x.
Key Financial Data